Skip to main content
Fig. 4 | Cell & Bioscience

Fig. 4

From: Ribosomal protein L34 is a potential prognostic biomarker and therapeutic target in hilar cholangiocarcinoma

Fig. 4

Kaplan-Meier curves of overall survival (OS) in patients with hilar cholangiocarcinoma. a OS was significantly worse in patients with regional lymph node metastasis than in those without lymph node metastasis (1.68 years vs 2.72 years, P = 0.001); b OS was significantly worse in patients with positive surgical margins than in those with negative surgical margins (1.64 years vs 2.46 years, P = 0.013); c OS was significantly worse in patients with advanced disease stage than in those with early disease stage (1.82 years vs 2.96 years, P = 0.003); d OS was significantly worse in patients with RPL34-positive tumors than in those with RPL34-negative tumors (1.70 years vs 3.63 years, P < 0.001)

Back to article page